Minnesota Drugmaker Cited for Cleaning Deficiencies By Sam | April 29, 2019 The FDA hit Minnesota generic drug manufacturer Upsher Smith Laboratories with a Form 483 over cleaning and batch production violations at its Plymouth facility. Source: Drug Industry Daily Posted in Drug Industry Daily